Article in The Laryngoscope, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Nicole MeeksDepartment of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0009-0007-4021-8636
Ashtyn McAdooDepartment of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jaclyn LeeDepartment of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Marisa HomDepartment of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Gary SmithDepartment of Nuclear Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Melanie HicksDepartment of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Kyle MannionDepartment of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Eben RosenthalDepartment of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0003-0294-5203
Michael C TopfDepartment of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-6728-3418
Funding
Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
Secondary Molecular Imaging (SMI) for head and neck cancerR01CA279249 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI EBEN L. ROSENTHAL · 2024 to 2026
$1.1M
Augmented Reality to Guide Head and Neck Cancer SurgeryK08CA293255 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Michael Topf · 2024 to 2026
$645k
American Academy of Otolaryngology-Head and Neck Surgery 1058419National Institute of Health Sciences 1R01CA279249-01A1NCATS NIH HHS UL1 TR002243NCI NIH HHS K08 CA293255NCI NIH HHS K12 CA090625NCI NIH HHS R01 CA279249Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center UL1TR002243
6 · The paper itself
Abstract
Squamous cell carcinoma of unknown primary continues to be a diagnostic challenge. We present a case where a novel molecular imaging agent aided the identification of additional lesions missed on traditional imaging, ultimately leading to diagnosis and a change in management.
Indexed as
Carcinoma, Squamous CellHead and Neck NeoplasmsMolecular ImagingNeoplasms, Unknown PrimaryFluorodeoxyglucose F18HumansPositron Emission Tomography Computed TomographyRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticalshead and neckimmuno‐PETmolecular imagingnasopharyngeal carcinomapositron‐emission tomography
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Non-FDG-Avid Metastasis Detected by Molecular Imaging in Unknown Primary of the Head and Neck. · full record | OpenQuestion